Diabetes Mellitus, Experimental
"Diabetes Mellitus, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
| Descriptor ID |
D003921
|
| MeSH Number(s) |
C18.452.394.750.074 C19.246.240 E05.598.500.374
|
| Concept/Terms |
Streptozotocin Diabetes- Streptozotocin Diabetes
- Diabetes, Streptozotocin
- Streptozocin Diabetes
- Diabete, Streptozocin
- Diabetes, Streptozocin
- Streptozocin Diabete
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Experimental".
This graph shows the total number of publications written about "Diabetes Mellitus, Experimental" by people in this website by year, and whether "Diabetes Mellitus, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 0 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 3 | 3 | 6 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 4 | 2 | 6 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 0 | 3 |
| 2013 | 3 | 4 | 7 |
| 2014 | 2 | 1 | 3 |
| 2015 | 4 | 1 | 5 |
| 2016 | 5 | 4 | 9 |
| 2017 | 3 | 0 | 3 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 2 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 4 | 2 | 6 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 0 | 2 |
| 2025 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Experimental" by people in Profiles.
-
Bioinspired Provisional Matrix Stimulates Regenerative Healing of Diabetic Wounds. Wound Repair Regen. 2025 Sep-Oct; 33(5):e70088.
-
Microbiota-derived corisin accelerates kidney fibrosis by promoting cellular aging. Nat Commun. 2025 Aug 25; 16(1):7591.
-
Temporal Regulation of Early-Stage Cytokine Expression in Diabetic Wound Healing Under Negative Pressure Wound Therapy. Int J Mol Sci. 2025 May 13; 26(10).
-
Sustained ROS scavenging and pericellular oxygenation by lignin composites rescue HIF-1a and VEGF levels to improve diabetic wound neovascularization and healing. Acta Biomater. 2025 Aug; 202:205-215.
-
Pentoxifylline protects memory performance in streptozotocin-induced diabetic rats. Brain Res. 2025 Jan 15; 1847:149319.
-
Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes. Cardiovasc Res. 2024 10 14; 120(12):1456-1471.
-
NDUFS4 regulates cristae remodeling in diabetic kidney disease. Nat Commun. 2024 Mar 04; 15(1):1965.
-
No NLRP3 inflammasome activity in kidney epithelial cells, not even when the NLRP3-A350V Muckle-Wells variant is expressed in podocytes of diabetic mice. Front Immunol. 2023; 14:1230050.
-
Secretogranin III Selectively Promotes Vascular Leakage in the Deep Vascular Plexus of Diabetic Retinopathy. Int J Mol Sci. 2023 Jun 23; 24(13).
-
Induction of Type 2 Diabetes in Mice to Understand Vascular Changes That Drive Diabetic Retinopathy. Methods Mol Biol. 2023; 2678:1-12.